Related Experiment Video

Updated: Jul 18, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Hepatitis C and arthritis: an update

Aja M Sanzone1, Rodolfo E Bégué

  • 1Pediatric Infectious Diseases, Combined Fellowship Training Program of Tulane University and Louisiana State University Health Sciences Center, Children's Hospital, 1430 Tulane Avenue, New Orleans, LA 70112, USA.

Infectious Disease Clinics of North America
|November 23, 2006
PubMed

Insights

Chronic hepatitis C virus (HCV) infection can cause arthritis, but its direct link and optimal treatment remain unclear. Treatment decisions for HCV arthritis require careful consideration due to potential medication side effects and variable responses.

Area of Science:

  • Hepatology
  • Rheumatology
  • Virology

Background:

  • Extrahepatic symptoms are frequent in chronic hepatitis C virus (HCV) infection.
  • Arthritis is a notable extrahepatic manifestation, potentially linked to autoimmune processes or chronic inflammation.
  • The precise relationship between HCV infection and arthritis is not fully understood.

Purpose of the Study:

  • To review the current understanding of arthritis in the context of chronic hepatitis C virus infection.
  • To discuss the challenges in attributing arthritis specifically to HCV infection versus general inflammation.
  • To explore potential treatment strategies and their limitations for HCV-associated arthritis.

Main Methods:

  • Literature review of studies investigating arthritis in chronic hepatitis C virus infection.
  • Analysis of the proposed mechanisms linking HCV to arthritic conditions.
  • Evaluation of existing treatment guidelines and their applicability to HCV arthritis.

Main Results:

  • The literature is insufficient to definitively guide the treatment of HCV arthritis.
  • Arthritis may occur independently or as part of autoimmune phenomena associated with HCV.
  • Standard antirheumatic treatments carry risks, including potential hepatotoxicity, and show variable efficacy.

Conclusions:

  • The exact cause of arthritis in HCV patients remains unclear, necessitating further research.
  • Treatment of HCV arthritis requires caution due to potential drug toxicity and unpredictable responses.
  • Individualized, case-by-case treatment decisions are essential for managing HCV-associated arthritis.

More Related Videos

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...